GREEN SYNTHESIS OF PYRAZOLO [3,4]-PYRIMIDINE-THIONES USING IONIC LIQUID 2-METHYL-IMIDAZOLIUM-OXALATE AS POTENT EHRLICH ASCITES CARCINOMA RECEPTOR ANTAGONISTS
Objective: Pyrazolopyrimidines are heterocyclic molecules containing nitrogen as the main composition, and hence, they exhibit pharmacological efficacy. They are analogs of purines so that possessing wide applications in the field of medicinal chemistry. The main objective of this study is to synthesize different derivatives of pyrazole-pyrimidine classes by adopting simple methodology as well as by employing green chemistry. The purpose of the synthesis of these molecules is to study the antitumor activity against Ehrlich ascites carcinoma (EAC) cell lines.
Methods: After literature studies, it makes us to involve in the research of synthetic organic chemistry, especially to synthesize new compounds of pyrazolopyrimidines. We are reported solvent-free synthesis of pyrazolo [3,4-d]-pyrimidine-thiones through ethyl acetoacetate, hydrazine hydrate, thiourea, and different benzaldehydes. An ionic liquid 2-methyl-imidazolium-oxalate catalyzed the reactions under ultrasonication bath. Both conventional and ultrasonic methods were employed and comparison studies have been made. It was found that ultrasonic method completed the reaction quicker than the conventional method. All the synthesized compounds were confirmed their structures by 1HNMR, Fourier transform infrared, 13C-NMR, and elemental analysis spectra. The compounds were tested for in vitro anticancer activity against EAC cell lines. Most compounds revealed significant anticancer activity relative to doxorubicin as a positive control with inhibitory concentration (IC50) values.
Results: Ultrasonication method is a simple method under which all the reactions were completed at faster time (<7 min) compared to the convention method. Among eight molecules, 8a and 8d completed the reactions at a faster rate. We reported IC50 values of all the molecules, in which 8e and 8g were exhibited excellent potency against EAC cell lines at different concentrations .
Conclusions: Ultrasonication method is an excellent method for the organic synthesis. We are herein reported that under this method, all the reactions are completed within 7 min. Hence, it is superior method than the conventional method. All synthesized molecules have shown good inhibitor potency against EAC cell lines. Among them, two molecules 8e and 8g have shown excellent inhibitor potency.
2. Aggarwal R, Masan E, Kaushik P, Kaushik D, Sharma C, Aneja KR. Synthesis and biological evaluation of 7-trifluoromethylpyrazolo[1,5-a] pyrimidines as anti-inflammatory and antimicrobial agents. J Fluor Chem 2014;168:16-24.
3. Kaping S, Kalita U, Sunn M, Singha LI., Vishwakarma JN. A facile, regioselective synthesis of pyrazolo[1,5-a]pyrimidine analogs in the presence of KHSO4 in aqueous media assisted by ultrasound and their anti-inflammatory and anti-cancer activities. Monatsh Chem 2016;147:1257-76.
4. Deshmukh S, Dingore K, Gaikwad V, Jachak M. An efficient synthesis of pyrazolo[1,5-a]pyrimidines and evaluation of their antimicrobial activity. J Chem Sci 2016;128:1459-68.
5. El-Mekabaty A, Habib OM, Moawad EB, Hasel A. Synthesis and antioxidant activity of new pyrazolo[1,5-a]pyrimidine derivatives incorporating a thiazol-2-yldiazenyl moiety. J Heterocycl Chem 2016;53:1820-6.
6. Hassan AS, Masoud DM, Sroor FM, Askar AA. Synthesis and biological evaluation of pyrazolo[1,5-a]pyrimidine-3-carboxamide as antimicrobial agents. Med Chem Res 2017;26:2909-10.
7. Kumar AK, Bodke YD, Lakra PS, Sambasivam G, Bhat KG. Design, synthesis and anti-cancer evaluation of a novel series of pyrazolo[1,5-a] pyrimidine substituted diamide derivatives. Med Chem Res 2017;26:714-44.
8. Rahmouni A, Souiei S, Belkacem MA, Romdhane A, Bouajila J, Ben Jannet H, et al. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents. Bioorg Chem 2016;66:160-8.
9. Zhao M, Ren H, Chang J, Zhang D, Yang Y, He Y, et al. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo. Eur J Med Chem 2016;119:183-96.
10. Li J, Zhao YF, Zhao XL, Yuan XY, Gong P. Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines. Arch Pharm (Weinheim) 2006;339:593-7.
11. Ahmed OM, Mohamed MA, Ahmed RR, Ahmed SA. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a] pyrimidines. Eur J Med Chem 2009;44:3519-23.
12. Abdel-Aziz HA, Saleh TS, El-Zahabi HS. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety. Arch Pharm (Weinheim) 2010;343:24-30.
13. Hassan AS, Hafez, TS, Osman SA, Ali MM. Synthesis and in vitro cytotoxic activity of novel pyrazolo[1,5-a]pyrimidines and related Schiff bases. Turk J Chem 2015;39:1102-13.
14. Ribeiro DA, Marques ME, Salvador DM. In vitro cytotoxic and non-genotoxic effects of gutta-percha solvents on mouse lymphoma cells by single cell gel (comet) assay. Braz Dent J 2006;17:228-32.
15. Shaikh IS, Zaheer Z, Mokale NS, Lokwani KD. Development of new pyrazole hybrids as antitubercular agents: Synthesis, biological evaluation and molecular docking study. Int J Pharm Pharm Sci 2017;9:50-6.
16. Murulidharan V, Deepti CA, Raja S. A review on anti-inflammatory potential of substituted pyrazoline derivatives synthesised from chalcones. Int J Pharm Pharm Sci 2018;10:9.
17. Humphrey W, Dalke A, Schulten K. VMD-visual molecular dynamics. J Mol Graph 1996;14:33-5.
18. MTT Cell Proliferation Assay Instruction Guide – ATCC, VA, USA. Available from: http://www.atcc.org
19. Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986;94:57-63.
20. Alley MC, Scudiero DA, Monks A, Czerwinski M, Shoemaker R 2nd, Boyd MR. Validation of an automated microculture tetrazolium assay (MTA) to assess growth and drug sensitivity of human tumor cell lines. Proc Am Assoc Cancer Res 1986;27:389.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.